Why the study?
How does Cyclosporine A modulate endothelial and vascular smooth muscle function?
How does Cyclosporine A modulate endothelial and vascular smooth muscle function?
Cyclosporine A induces complex alterations in vascular tone by impairing endothelial vasodilation and augmenting smooth muscle contraction, which may contribute to its cardiovascular side effects.
Answers are grounded in this paper and cite their sources.
May underlie cyclosporine-associated hypertension; leaves open prospective human studies on vascular-targeted mitigation.
Cyclosporine A is an efficient immunosuppressive agent, however, its use is associated with complex alterations of vascular tone. Numerous clinical and experimental observations indicate acute and chronic effects of cyclosporine A that are modulating endothelial and vascular smooth muscle function. Cyclosporine A impairs the vasodilator function of the endothelium; at the vascular smooth muscle contractions to angiotensin II are augmented, whereas conflicting results were obtained with other vasoconstrictors. Furthermore, cyclosporine A may alter circulating and locally released vasoactive hormons, such as renin/angiotensin II, catecholamines and endothelin-1. The cellular mechanisms mediating the effects of cyclosporine A in the arterial wall are not completely understood, but several experimental findings give a more and more detailed picture of potentially involved systems.
No takes yet. Share an insight, caveat, or question.
Götze et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: